Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Alzheimer’s disease pipeline takes multiple hits

Following a number of recent failures of clinical compounds, researchers are shifting the focus from late-stage disease to early-stage or prophylactic therapies

ParagonRx appoints ex-FDA medical officer

Dr Stephen Sun joins consultancy as chief medical officer

- PMLiVE

Novartis orphan drug wins ‘breakthrough’ status from FDA

Bimagrumab could be first treatment for rare life-threatening muscle-wasting condition

EMA prepares for digital signature introduction

From next month will accept digital signatures for certain procedures

- PMLiVE

Eisai sues DEA over Fycompa scheduling

Pharma company won FDA approval in 2012 but still lacks DEA verdict

Shire hires adviser on takeover threat

Reports suggest it could be the latest Irish pharma company to be acquired

- PMLiVE

Doctors.net.uk appoints new business development manager

Amanda Taylor joins from life sciences organisation OBN UK

James D’Arecca joins Actavis

Moves from Bausch & Lomb to take up accounting role

- PMLiVE

Offshoring data management

Offshoring is not just the future for pharmaceutical market research, it is what’s happening right now

- PMLiVE

GSK gets OK for second quadrivalent flu vaccine in US

FDA approves Flulaval Quadrivalent

Novartis building

Novartis drawn into Chinese corruption probe

Former sales rep files bribery complaint about Sandostatin LAR prescribing practices

- PMLiVE

Outcomes shape the new European payer networks

In the new commercial reality of cost-constrained healthcare environments the payer is everywhere

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links